News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,348 Results
Type
Article (41805)
Company Profile (280)
Press Release (683261)
Multimedia
Podcasts (76)
Webinars (18)
Section
Business (207095)
Career Advice (2031)
Deals (35907)
Drug Delivery (102)
Drug Development (81533)
Employer Resources (173)
FDA (16541)
Job Trends (15052)
News (349673)
Policy (33012)
Tag
Academia (2601)
Accelerated approval (19)
Adcomms (24)
Allergies (123)
Alliances (50488)
ALS (144)
Alzheimer's disease (1613)
Antibody-drug conjugate (ADC) (245)
Approvals (16687)
Artificial intelligence (452)
Autoimmune disease (107)
Automation (32)
Bankruptcy (365)
Best Places to Work (11705)
BIOSECURE Act (20)
Biosimilars (161)
Biotechnology (176)
Bladder cancer (136)
Brain cancer (48)
Breast cancer (524)
Cancer (4149)
Cardiovascular disease (344)
Career advice (1713)
Career pathing (34)
CAR-T (239)
CDC (42)
Cell therapy (636)
Cervical cancer (33)
Clinical research (68786)
Collaboration (1401)
Company closure (4)
Compensation (979)
Complete response letters (45)
COVID-19 (2711)
CRISPR (82)
C-suite (633)
Cystic fibrosis (135)
Data (5223)
Decentralized trials (2)
Denatured (24)
Depression (106)
Diabetes (444)
Diagnostics (6972)
Digital health (39)
Diversity (11)
Diversity, equity & inclusion (45)
Drug discovery (203)
Drug pricing (163)
Drug shortages (28)
Duchenne muscular dystrophy (202)
Earnings (90481)
Editorial (48)
Employer branding (21)
Employer resources (151)
Events (117499)
Executive appointments (942)
FDA (19159)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1282)
Gene editing (178)
Generative AI (38)
Gene therapy (514)
GLP-1 (899)
Government (4660)
Grass and pollen (6)
Guidances (375)
Healthcare (19057)
HIV (48)
Huntington's disease (38)
IgA nephropathy (74)
Immunology and inflammation (222)
Immuno-oncology (23)
Indications (67)
Infectious disease (2949)
Inflammatory bowel disease (178)
Inflation Reduction Act (13)
Influenza (98)
Intellectual property (200)
Interviews (318)
IPO (16772)
IRA (49)
Job creations (3701)
Job search strategy (1440)
Kidney cancer (15)
Labor market (78)
Layoffs (544)
Leadership (28)
Legal (7993)
Liver cancer (89)
Longevity (12)
Lung cancer (590)
Lymphoma (301)
Machine learning (32)
Management (59)
Manufacturing (632)
MASH (152)
Medical device (13813)
Medtech (13848)
Mergers & acquisitions (20067)
Metabolic disorders (1106)
Multiple sclerosis (139)
NASH (16)
Neurodegenerative disease (242)
Neuropsychiatric disorders (61)
Neuroscience (2650)
NextGen: Class of 2025 (6563)
Non-profit (4553)
Now hiring (59)
Obesity (508)
Opinion (246)
Ovarian cancer (146)
Pain (157)
Pancreatic cancer (182)
Parkinson's disease (243)
Partnered (29)
Patents (425)
Patient recruitment (353)
Peanut (54)
People (59088)
Pharmaceutical (64)
Pharmacy benefit managers (25)
Phase I (21411)
Phase II (30283)
Phase III (22570)
Pipeline (3407)
Policy (257)
Postmarket research (2568)
Preclinical (9155)
Press Release (66)
Prostate cancer (211)
Psychedelics (43)
Radiopharmaceuticals (266)
Rare diseases (640)
Real estate (6037)
Recruiting (69)
Regulatory (23961)
Reports (51)
Research institute (2407)
Resumes & cover letters (353)
Rett syndrome (20)
RNA editing (12)
RSV (72)
Schizophrenia (132)
Series A (205)
Series B (157)
Service/supplier (12)
Sickle cell disease (78)
Special edition (20)
Spinal muscular atrophy (152)
Sponsored (37)
Startups (3683)
State (2)
Stomach cancer (16)
Supply chain (96)
Tariffs (79)
The Weekly (50)
Vaccines (923)
Venture capital (70)
Weight loss (329)
Women's health (65)
Worklife (17)
Date
Today (93)
Last 7 days (592)
Last 30 days (3481)
Last 365 days (30582)
2025 (28353)
2024 (35519)
2023 (40432)
2022 (51550)
2021 (56105)
2020 (54582)
2019 (46972)
2018 (35405)
2017 (32523)
2016 (31989)
2015 (38123)
2014 (31796)
2013 (26920)
2012 (29106)
2011 (29799)
2010 (27788)
Location
Africa (751)
Alabama (74)
Alaska (7)
Arizona (284)
Arkansas (13)
Asia (39583)
Australia (6495)
California (10106)
Canada (3005)
China (911)
Colorado (421)
Connecticut (442)
Delaware (285)
Europe (86074)
Florida (1490)
Georgia (327)
Hawaii (2)
Idaho (61)
Illinois (755)
India (51)
Indiana (477)
Iowa (20)
Japan (343)
Kansas (123)
Kentucky (36)
Louisiana (24)
Maine (70)
Maryland (1291)
Massachusetts (7296)
Michigan (294)
Minnesota (575)
Mississippi (5)
Missouri (120)
Montana (30)
Nebraska (26)
Nevada (109)
New Hampshire (77)
New Jersey (2735)
New Mexico (30)
New York (2697)
North Carolina (1367)
North Dakota (9)
Northern California (4783)
Ohio (298)
Oklahoma (20)
Oregon (37)
Pennsylvania (2082)
Puerto Rico (19)
Rhode Island (44)
South America (1118)
South Carolina (56)
South Dakota (1)
Southern California (3927)
Tennessee (158)
Texas (1550)
United States (36250)
Utah (305)
Vermont (1)
Virginia (235)
Washington D.C. (78)
Washington State (833)
West Virginia (4)
Wisconsin (97)
Wyoming (2)
725,348 Results for "cellanyx diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
October 14, 2025
·
2 min read
Press Releases
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
November 3, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30
October 1, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit
September 10, 2025
·
1 min read
Press Releases
Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 30, 2025
·
3 min read
Press Releases
Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
October 29, 2025
·
3 min read
Press Releases
Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results
August 15, 2025
·
9 min read
Press Releases
Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains
September 12, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. Signs Strategic MOU with Partner in Kingdom of Saudi Arabia to Introduce Co-Dx™ PCR Platform to Middle East
September 17, 2025
·
4 min read
Press Releases
Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.
August 19, 2025
·
2 min read
1 of 72,535
Next
